Improving Medication Adherence Using an Adaptive mHealth Intervention in Adolescents With Asthma.
Sponsor: Children's Hospital Medical Center, Cincinnati
Trial Details
| Condition | Asthma in Children, Asthma Chronic |
| Intervention | Asthma Ctrl; Asthma Ctrl+; Control |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 389 |
| Est. Completion | 1 Jan 2030 |
| Last Updated | 11 May 2026 |
Primary Outcome
Electronically Monitored Controller Medication Adherence
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Patient age between 12-18 years * Patient is diagnosed with severe-persistent or moderate-persistent asthma per NAEPP asthma guidelines * Patient is prescribed at least one daily inhaled controller medication or a daily combination inhaled corticosteroid and long-acting beta-agonist and a beta-agonist bronchodilator * English fluency for patient, caregiver, and clinician Exclusion Criteria: * Significant cognitive deficits that may interfere with comprehension per medical team or chart review * Diagnosis of serious mental illness (e.g., schizophrenia) * Diagnosis of pervasive developmental disorder * Active chronic disease apart from asthma or allergic disease (e.g. Bronchiectasis, pulmonary hypertension, and moderate or severe tracheomalacia) * Patient receives school administered daily controller medication at the time of the enrollment visit
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service